Extracorporeal membrane oxygenation for adults with active malignancy: Is there difference to clinical outcome between hematologic and oncologic?

C. Park (Iksan, Jeollabuk-do, Republic of Korea), E. Jung (Iksan, Jeollabuk-do, Republic of Korea), K. Hwang (Iksan, Jeollabuk-do, Republic of Korea), J. Jung (Iksan, Jeollabuk-do, Republic of Korea), H. Im (Iksan, Jeollabuk-do, Republic of Korea), H. Kim (Iksan, Jeollabuk-do, Republic of Korea)

Source: Virtual Congress 2020 – Novel findings regarding acute respiratory distress syndrome, extra corporeal membrane oxygenation and weaning from mechanical ventilation
Disease area: Respiratory critical care

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Park (Iksan, Jeollabuk-do, Republic of Korea), E. Jung (Iksan, Jeollabuk-do, Republic of Korea), K. Hwang (Iksan, Jeollabuk-do, Republic of Korea), J. Jung (Iksan, Jeollabuk-do, Republic of Korea), H. Im (Iksan, Jeollabuk-do, Republic of Korea), H. Kim (Iksan, Jeollabuk-do, Republic of Korea). Extracorporeal membrane oxygenation for adults with active malignancy: Is there difference to clinical outcome between hematologic and oncologic?. 3440

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012

EOLIA trial: the future of extracorporeal membrane oxygenation in acute respiratory distress syndrome therapy?
Source: Breathe, 15 (3) 244; 10.1183/20734735.0363-2018
Year: 2019



Early physiotherapy in the clinical course of patients on Veno-Venous Extracorporeal Membrane Oxygenation.
Source: International Congress 2018 – Acutely hospitalised patients: physiotherapy interventions and assessment methods
Year: 2018


Extracorporeal photoapheresis in the treatment of chronic lung rejection: preliminary clinical and immunological results on a small cohort of lung recipients
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008

Extracorporeal photopheresis after lung transplantation: a 10-year single-centre experience
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008

The use of extracorporeal membrane oxygenation (ECMO) in severe delayed graft dysfunction after lung transplant
Source: Annual Congress 2011 - Lung transplantation
Year: 2011

Lung function during the first year of life in infants following extracorporeal membrane oxygenation
Source: Eur Respir J 2003; 22: Suppl. 45, 383s
Year: 2003

Late Breaking Abstract - Long-term outcome of perioperative extracorporeal membrane oxygenation (ECMO) in patients undergoing pulmonary endarterectomy (PEA).
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017

Extracorporeal photopheresis: an effective treatment for pulmonary graft versus host disease
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020


Late Breaking Abstract: Extracorporeal membrane oxygenation in fully awake patients with right heart failure as bridge to transplantation
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010


Extracorporeal life support in lung failure and lung transplant bridging: when and how
Source: Virtual Congress 2020 – Extracorporeal life support in lung failure and lung transplant bridging: when and how
Year: 2020

Extracorporeal membrane oxygenation for the treatment of acute exacerbation of interstitial lung diseases
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights
Year: 2017



Extracorporeal membrane oxygenation (ECMO) for near fatal asthma refractory to conventional ventilation
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016


Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy
Source: Eur Respir J 2009; 33: 551-558
Year: 2009



Extracorporeal membrane oxygenation as bridge in patients with non-iatrogenic massive hemoptysis
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012


Deterioration of exercise capacity after neonatal extracorporeal membrane oxygenation
Source: Eur Respir J 2011; 38: 1098-1104
Year: 2011



Extracorporeal membrane oxygenation as rescue therapy for severe ARDS due to autoimmune diffuse alveolar haemorrhage
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019


Current outcome after lung transplantation
Source: Annual Congress 2012 - Lung transplantation in 2012: where are we?
Year: 2012


Inflammatory and microbiological associations with near-fatal asthma requiring extracorporeal membrane oxygenation
Source: ERJ Open Res, 6 (1) 00267-2019; 10.1183/23120541.00267-2019
Year: 2020



Long-term management, functional outcome and results
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=179
Year: 2003